Palivizumab prophylaxis during respiratory syncytial virus outbreak in the neonatal intensive care unit

被引:0
|
作者
Alan, Serdar [1 ]
Cakir, Ufuk [1 ]
Erdeve, Omer [1 ]
Atasay, Begum [1 ]
Arsan, Saadet [1 ]
机构
[1] Ankara Univ, Fac Med, Dept Pediat, Div Neonatol, TR-06100 Ankara, Turkey
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:237 / 238
页数:2
相关论文
共 50 条
  • [41] Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
    Bjornson, Candice
    Chan, Parco
    Li, Abby
    Paes, Bosco
    Lanctot, Krista L.
    Mitchell, Ian
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (06) : 1113 - 1118
  • [42] Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
    Taylor, Richard S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (15) : E523 - E523
  • [43] Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
    Lekic, Envera
    Dragas, Ljubinka
    Nikcevic, Drasko
    Lekic, Jasmina
    Dedic, Ana
    Sulovic, Ljiljana
    TURKISH JOURNAL OF PEDIATRICS, 2024, 66 (02) : 161 - 170
  • [44] Consensus conference on the appropriateness of palivizumab prophylaxis in respiratory syncytial virus disease
    Pignotti, Maria Serenella
    Leo, Maria Carmela
    Pugi, Alessandra
    De Masi, Salvatore
    Biermann, Klaus Peter
    Galli, Luisa
    Rosati, Giovanni Vitali
    Buonocore, Giuseppe
    Mugelli, Alessandro
    Dani, Carlo
    Lucenteforte, Ersilia
    Bellini, Francesca
    Donzelli, Giampaolo
    PEDIATRIC PULMONOLOGY, 2016, 51 (10) : 1088 - 1096
  • [45] Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
    Olchanski, Natalia
    Hansen, Ryan N.
    Pope, Elle
    D'Cruz, Brittany
    Fergie, Jaime
    Goldstein, Mitchell
    Krilov, Leonard R.
    McLaurin, Kimmie K.
    Nabrit-Stephens, Barbara
    Oster, Gerald
    Schaecher, Kenneth
    Shaya, Fadia T.
    Neumann, Peter J.
    Sullivan, Sean D.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (03):
  • [46] Palivizumab Utilization and Compliance: Trends in Respiratory Syncytial Virus Prophylaxis in Florida
    Hampp, Christian
    Saidi, Arwa S.
    Winterstein, Almut G.
    JOURNAL OF PEDIATRICS, 2010, 156 (06): : 953 - U130
  • [47] Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units
    Kurz, H.
    Herbich, K.
    Janata, O.
    Sterniste, W.
    Bauer, K.
    JOURNAL OF HOSPITAL INFECTION, 2008, 70 (03) : 246 - 252
  • [48] FACTORS CONTRIBUTING TO POOR COMPLIANCE OF PALIVIZUMAB RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
    Pareek, A.
    DeVincenzo, J.
    Rea, H.
    Pham, T.
    DeVincenzo, J. P.
    Harrison, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 395 - 396
  • [49] The Impact of Palivizumab for Respiratory Syncytial Virus Prophylaxis on Preschool Childhood Asthma
    Hasson, Hannah Ora
    Bachar, Yoav
    Hazan, Itai
    Golan-Tripto, Inbal
    Goldbart, Aviv
    Greenberg, David
    Hazan, Guy
    VACCINES, 2024, 12 (11)
  • [50] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab - Reply
    Sorbero, Melony E. S.
    ElHassan, Nahed O.
    Hall, Caroline B.
    Stevens, Timothy P.
    Dick, Andrew W.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (05): : 520 - 520